Investors applaud ATL’s Q1 results

Article

Ultrasound vendor ATL appears to be one of the few medical imaging firms these days to get an even break in the financial markets. Investors bid the Bothell, WA, company's shares higher on April 24 after the company released financial results that

Ultrasound vendor ATL appears to be one of the few medical imaging firms these days to get an even break in the financial markets. Investors bid the Bothell, WA, company's shares higher on April 24 after the company released financial results that indicated a 6% increase in revenues, although net income was reduced due to expenses associated with the launch of its new HDI 1000 scanner. ATL's stock jumped $3.88, or 13%, to close at $33.25 on April 24.

For the quarter (end-March), ATL had revenues of $100.1 million, compared with $94.8 million in the second quarter of 1996. Net income stood at $2.1 million, compared with $3 million in the same period last year. ATL said that the results for the most recent quarter included launch expenses for HDI 1000, and that it expected launch expenses of $2 million to $4 million in the second quarter.

HDI 1000 uses software in place of hardware to save costs in system manufacturing (SCAN 3/5/97). Orders for the scanner are exceeding expectations, according to Dennis Fill, chairman and CEO. HDI 1000 will begin shipping this quarter.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.